Status:
UNKNOWN
Effect of Low-dose Esketamine Combined With Target-controlled Infusion of Propofol for Painless Gastrointestinal Endoscopy
Lead Sponsor:
Tianjin Union Medical Center
Conditions:
Pain
Anesthesia
Eligibility:
All Genders
18-75 years
Phase:
NA
Brief Summary
Purpose: 1. To determine the efficacy of low-dose esketamine in painless gastrointestinal endoscopy. 2. To determine the safety of low-dose esketamine in painless gastrointestinal endoscopy. 3. To pro...
Detailed Description
Keeping spontaneous breathing anesthesia can provide patients with comfortable diagnosis and treatment experience during gastrointestinal endoscopy, which is a vital prerequisite for the large-scale d...
Eligibility Criteria
Inclusion
- Subject's American Society of Anesthesiologists physical status is I-III.
- Subject has no symptoms of allergy to anesthetics.
- Subject has no contraindications for gastrointestinal endoscopy.
- Subject has given written informed consent to participate.
Exclusion
- Subject's BMI \<18 or \>30
- Subject has poorly controlled or untreated hypertension.
- Subject has severe ischemic heart disease.
- Subject is an untreated or undertreated patient with hyperthyroidism.
- Subject has used drugs that affect their central nervous system.
- .Subject has mental illness.
- .Subject has epilepsy.
- .Subject has a history of chronic pain.
- .Subject is pregnant or breast-feeding.
Key Trial Info
Start Date :
December 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2022
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04691076
Start Date
December 1 2020
End Date
February 1 2022
Last Update
December 31 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tianjin Union Medical Center
Tianjin, China, 300131